| Drug delivery to macrophages: challenges and opportunities Y Pei, Y Yeo Journal of Controlled Release 240, 202-211, 2016 | 113 | 2016 |
| Pharmacokinetics and biodistribution of recently-developed siRNA nanomedicines J Park, J Park, Y Pei, J Xu, Y Yeo Advanced drug delivery reviews 104, 93-109, 2016 | 87 | 2016 |
| Particle engineering for intracellular delivery of vancomycin to methicillin-resistant Staphylococcus aureus (MRSA)-infected macrophages Y Pei, MF Mohamed, MN Seleem, Y Yeo Journal of Controlled Release 267, 133-143, 2017 | 62 | 2017 |
| Surface modification of polymeric nanoparticles with M2pep peptide for drug delivery to tumor-associated macrophages L Pang, Y Pei, G Uzunalli, H Hyun, LT Lyle, Y Yeo Pharmaceutical research 36, 1-12, 2019 | 48 | 2019 |
| Antibacterial nanotruffles for treatment of intracellular bacterial infection MG Elnaggar, K Jiang, HE Eldesouky, Y Pei, J Park, SA Yuk, F Meng, ... Biomaterials 262, 120344, 2020 | 30 | 2020 |
| Small molecule delivery to solid tumors with chitosan-coated PLGA particles: A lesson learned from comparative imaging J Park, Y Pei, H Hyun, MA Castanares, DS Collins, Y Yeo Journal of Controlled Release 268, 407-415, 2017 | 23 | 2017 |
| Tigliane diterpene esters with IFN γ-inducing activity from the leaves of Aleurites fordii YH Pei, JW Kim, HB Kang, HK Lee, CS Kim, HH Song, YW Chin, SR Oh Bioorganic & medicinal chemistry letters 22 (6), 2318-2320, 2012 | 21 | 2012 |
| Selective estrogen receptor modulation by Larrea nitida on MCF-7 cell proliferation and immature rat uterus HN Ahn, SY Jeong, GU Bae, M Chang, D Zhang, X Liu, Y Pei, YW Chin, ... Biomolecules & therapeutics 22 (4), 347, 2014 | 20 | 2014 |
| Topical application of zwitterionic chitosan suppresses neutrophil-mediated acute skin inflammation SW Lee, HJ Park, Y Pei, Y Yeo, S Hong International journal of biological macromolecules 158, 1184-1193, 2020 | 14 | 2020 |
| Triterpenes with cytotoxicity from the leaves of Vernicia fordii YH Pei, OK Kwon, JS Lee, HJ Cha, KS Ahn, SR Oh, HK Lee, YW Chin Chemical and Pharmaceutical Bulletin 61 (6), 674-677, 2013 | 13 | 2013 |
| Synthesis and bioactivity of readily hydrolysable novel cationic lipids for potential lung delivery application of mRNAs Y Pei, Y Bao, C Sacchetti, J Brady, K Gillard, H Yu, S Roberts, K Rajappan, ... Chemistry and physics of lipids 243, 105178, 2022 | 7 | 2022 |
| Spiroketones and a Biphenyl Analog from Stems and Leaves of Larrea nitida and Their Inhibitory Activity against IL-6 Production J Ahn, Y Pei, HS Chae, SH Kim, YM Kim, YH Choi, J Lee, M Chang, ... Molecules 23 (2), 302, 2018 | 2 | 2018 |
| Development of poly (lactide-co-glycolide) microparticles for sustained delivery of meloxicam Y Pei, J Wang, NU Khaliq, F Meng, KA Oucherif, J Xue, SD Horava, ... Journal of Controlled Release 353, 823-831, 2023 | 1 | 2023 |
| Lipid formulations containing nucleic acids and methods of treatment for cystic fibrosis CG Perez-Garcia, K Tachikawa, D Matsuda, P Chivukula, PP Karmali, ... US Patent App. 18/052,505, 2023 | | 2023 |
| WS16. 03 LUNAR-CF: an mRNA replacement approach for cystic fibrosis lung disease D Geller, CG Perez-Garcia, Y Pei, X Liu, J Engelhardt, C Hodges, ... Journal of Cystic Fibrosis 21, S31, 2022 | | 2022 |
| 663: LUNAR efficiently delivers mRNA into ferret airway epithelial cells in vitro and in vivo X Liu, M Luo, Y Pei, B Bao, Q Cai, B Liang, D Bartels, C Perez-Garcia, ... Journal of Cystic Fibrosis 20, S314-S315, 2021 | | 2021 |
| LUNAR®-CF, A Novel mRNA Therapeutic Approach to Correct the Root Cause of Cystic Fibrosis Lung Disease CG Perez-Garcia, Y Pei, Y Bao, P Karmali, X Liu, J Engelhardt, C Hodges, ... | | 2021 |
| LUNAR®-CF, an aerosolized mRNA replacement Therapy for Cystic Fibrosis Lung Disease CG Perez-Garcia, Y Pei, Y Bao, P Karmali, J Engelhardt, X Liu, C Hodges, ... PEDIATRIC PULMONOLOGY 55, S203-S203, 2020 | | 2020 |
| Particle Engineering for Intracellular Delivery of Antibiotics Y Pei Purdue University, 2018 | | 2018 |
| Phorbol type diterpene compound, pharmaceutical composition for treatment or prevention of viral infectious diseases including same SR Oh, JW Kim, YH Pei, HK Lee, HB Kang, DY Kim, KS Ahn US Patent 9,174,925, 2015 | | 2015 |
